Advisory Services Network’s Amicus Therapeutics FOLD Stock Holding History

Advisory Services Network’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.72K	Buy	+119	New	+$1.71K	﹤0.01%	4177
2020 Q4	–	Sell	-634	Closed	-$13K	–	3424
2020 Q3	$9K	Buy	+634	New	+$9.24K	﹤0.01%	2486
2020 Q2	–	Sell	-599	Closed	-$6K	–	1639
2020 Q1	$6K	Hold	599	–	–	﹤0.01%	2405
2019 Q4	$6K	Buy	+599	New	+$5.48K	﹤0.01%	2550
2018 Q3	–	Sell	-87	Closed	-$1K	–	2536
2018 Q2	$1K	Hold	87	–	–	﹤0.01%	2355
2018 Q1	$1K	Hold	87	–	–	﹤0.01%	2469
2017 Q4	$1K	Hold	87	–	–	﹤0.01%	2441
2017 Q3	$1K	Buy	+87	New	+$1.15K	﹤0.01%	2264

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Advisory Services Network's FOLD Position: Q1 2026 in Review

Advisory Services Network opened a new position in Amicus Therapeutics (FOLD) in Q1 2026: 119 shares worth $1.72K. The stake represents ﹤0.01% of the portfolio and ranks #4177 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in FOLD as recently as Q3 2020.

Advisory Services Network first reported a position in FOLD in Q3 2017 and has held it in 8 quarters since. The position peaked at $9K in Q3 2020. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Advisory Services Network held 119 shares of Amicus Therapeutics worth $1.72K as of Q1 2026.
Amicus Therapeutics was a new Advisory Services Network position in Q1 2026.
Amicus Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #4177 holding.
Advisory Services Network first reported a position in Amicus Therapeutics in Q3 2017 and has held it in 8 quarters since.
Advisory Services Network's Amicus Therapeutics position peaked at $9K in Q3 2020.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.